Stephen G. Machatha
2023
In 2023, Stephen G. Machatha earned a total compensation of $1.6M as Chief Development Officer at Aldeyra Therapeutics, a 38% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $113,175 |
---|---|
Option Awards | $1,089,483 |
Salary | $377,250 |
Other | $13,200 |
Total | $1,593,108 |
Machatha received $1.1M in option awards, accounting for 68% of the total pay in 2023.
Machatha also received $113.2K in non-equity incentive plan, $377.3K in salary and $13.2K in other compensation.
Rankings
In 2023, Stephen G. Machatha's compensation ranked 743rd out of 2,978 executives tracked by ExecPay. In other words, Machatha earned more than 75.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 743 | 75th |
Manufacturing | 425 | 74th |
Chemicals And Allied Products | 288 | 68th |
Drugs | 282 | 68th |
Pharmaceutical Preparations | 187 | 70th |
Machatha's colleagues
We found two more compensation records of executives who worked with Stephen G. Machatha at Aldeyra Therapeutics in 2023.